Sign in with Google. Opens in new tab
bearish

China Healthcare Weekly (Nov.3) - TCM VBP Update, ADC CXO's Logic Is Solid, "Ugly Move" Of Innovent

455 Views03 Nov 2024 01:39
The 3rd batch of TCM VBP will hit the performance of exclusive TCM varieties.Due to the "ugly move" of Innovent's management, we advise investors to sell its shares.The logic of ADC CXO is still valid
What is covered in the Full Insight:
  • Introduction
  • TCM VBP Update
  • ADC Market Insights
  • Innovent's Strategic Moves
  • Market Review and Risks
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
chart-bar
x